title: Effects of encapsulated niacin on metabolism and production of periparturient dairy cows.
abstract: Nicotinic acid (niacin) can suppress lipolysis, but responses to dietary niacin have been inconsistent in cattle. Our aim was to determine if 24 g/d of encapsulated niacin (EN; providing 9.6g/d of bioavailable nicotinic acid) alters lipid metabolism and productivity of transition cows. Beginning 21 d before expected calving, primiparous (n = 9) and multiparous (n = 13) cows (body condition score of 3.63 ± 0.08) were sequentially assigned within parity to EN (12 g provided with ration twice daily) or control through 21 d postpartum. Liver biopsies were collected on d -21, -4, 1, 7, and 21 relative to parturition. Blood samples were collected on d -21, -14, -7, -4, 1, 4, 7, 14, and 21 relative to parturition. On d 7 postpartum, a caffeine clearance test was performed to assess liver function, and on d 21 to 23 postpartum, blood samples were collected every 8h to monitor posttreatment nonesterified fatty acid (NEFA) responses. Data were analyzed using mixed models with repeated measures over time. A treatment × time × parity effect was observed on prepartum dry matter intake (DMI), which was caused by a 4 kg/d decrease in DMI of EN-treated multiparous cows compared with control multiparous cows during the final 4 d prepartum. A significant increase in plasma nicotinamide concentration occurred in EN-treated cows on d -7 and 21 relative to parturition. Prepartum glucose concentration decreased in treated animals, with no difference in plasma insulin concentration. Treatment × time × parity effects were detected for NEFA and β-hydroxybutyrate concentrations during the postpartum period. Plasma NEFA peaked at 1,467 ± 160 μM for control animals compared with 835 ± 154 μM for EN-treated animals. After treatments ended on d 21, no evidence was found for a plasma NEFA rebound in either parity group. A treatment × parity × time interaction was detected for liver triglyceride content, indicating a tendency for less liver triglyceride in EN-treated primiparous cows, but caffeine clearance rates were not affected by treatment. No treatment effects were observed for body condition score, body weight, energy balance, or milk or milk component production. A high dose of EN can decrease postpartum plasma NEFA concentration, but may also decrease prepartum DMI.
authors.affiliation: Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506, USA.
authors.forename: S D
authors.initials: SD
authors.lastname: Morey
authors.forename: L K
authors.initials: LK
authors.lastname: Mamedova
authors.forename: D E
authors.initials: DE
authors.lastname: Anderson
authors.forename: C K
authors.initials: CK
authors.lastname: Armendariz
authors.forename: E C
authors.initials: EC
authors.lastname: Titgemeyer
authors.forename: B J
authors.initials: BJ
authors.lastname: Bradford
mesh_terms: D020155:3-Hydroxybutyric Acid / Q000097:blood; D000818:Animals; D001824:Body Constitution / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D002417:Cattle; D019587:Dietary Supplements; D060467:Disease Resistance / Q000187:drug effects; D004435:Eating / Q000187:drug effects; D004734:Energy Metabolism / Q000187:drug effects*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D007774:Lactation / Q000502:physiology; D008099:Liver / Q000187:drug effects / Q000378:metabolism*; D008892:Milk / Q000737:chemistry / Q000378:metabolism; D009525:Niacin / Q000008:administration & dosage / Q000097:blood / Q000494:pharmacology*; D009539:Nicotinic Acids / Q000097:blood; D011247:Pregnancy; D011897:Random Allocation; D014803:Vitamin B Complex / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D005230:Fatty Acids, Nonesterified; D009539:Nicotinic Acids; D014803:Vitamin B Complex; C038997:nicotinanilide; D009525:Niacin; D020155:3-Hydroxybutyric Acid